nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—ALB—liver cancer	0.495	1	CbGaD
Prednisone—CYP2C19—Sorafenib—liver cancer	0.0383	0.325	CbGbCtD
Prednisone—ABCB1—Sorafenib—liver cancer	0.0309	0.262	CbGbCtD
Prednisone—ABCB1—Doxorubicin—liver cancer	0.0188	0.159	CbGbCtD
Prednisone—CYP3A4—Sorafenib—liver cancer	0.0185	0.157	CbGbCtD
Prednisone—CYP3A4—Doxorubicin—liver cancer	0.0112	0.0954	CbGbCtD
Prednisone—Neuritis—Epirubicin—liver cancer	0.00093	0.00448	CcSEcCtD
Prednisone—Connective tissue disorder—Sorafenib—liver cancer	0.000927	0.00447	CcSEcCtD
Prednisone—Hepatomegaly—Doxorubicin—liver cancer	0.000908	0.00438	CcSEcCtD
Prednisone—Fungal infection—Epirubicin—liver cancer	0.000899	0.00434	CcSEcCtD
Prednisone—Necrosis—Epirubicin—liver cancer	0.000885	0.00426	CcSEcCtD
Prednisone—Abscess—Epirubicin—liver cancer	0.000878	0.00423	CcSEcCtD
Prednisone—Flushing—Sorafenib—liver cancer	0.000876	0.00422	CcSEcCtD
Prednisone—Dermatitis atopic—Doxorubicin—liver cancer	0.000868	0.00418	CcSEcCtD
Prednisone—Neuritis—Doxorubicin—liver cancer	0.000861	0.00415	CcSEcCtD
Prednisone—Glycosuria—Epirubicin—liver cancer	0.000857	0.00413	CcSEcCtD
Prednisone—Angiopathy—Sorafenib—liver cancer	0.000856	0.00413	CcSEcCtD
Prednisone—Immune system disorder—Sorafenib—liver cancer	0.000852	0.00411	CcSEcCtD
Prednisone—Petechiae—Epirubicin—liver cancer	0.000844	0.00407	CcSEcCtD
Prednisone—Arrhythmia—Sorafenib—liver cancer	0.000843	0.00406	CcSEcCtD
Prednisone—Alopecia—Sorafenib—liver cancer	0.000834	0.00402	CcSEcCtD
Prednisone—Fungal infection—Doxorubicin—liver cancer	0.000832	0.00401	CcSEcCtD
Prednisone—Mental disorder—Sorafenib—liver cancer	0.000827	0.00398	CcSEcCtD
Prednisone—Malnutrition—Sorafenib—liver cancer	0.000821	0.00396	CcSEcCtD
Prednisone—Erythema—Sorafenib—liver cancer	0.000821	0.00396	CcSEcCtD
Prednisone—Necrosis—Doxorubicin—liver cancer	0.000819	0.00395	CcSEcCtD
Prednisone—Abscess—Doxorubicin—liver cancer	0.000812	0.00391	CcSEcCtD
Prednisone—Delirium—Epirubicin—liver cancer	0.000807	0.00389	CcSEcCtD
Prednisone—Glycosuria—Doxorubicin—liver cancer	0.000793	0.00382	CcSEcCtD
Prednisone—Amenorrhoea—Epirubicin—liver cancer	0.00079	0.00381	CcSEcCtD
Prednisone—Petechiae—Doxorubicin—liver cancer	0.000781	0.00376	CcSEcCtD
Prednisone—Viral infection—Epirubicin—liver cancer	0.000769	0.00371	CcSEcCtD
Prednisone—Arthropathy—Epirubicin—liver cancer	0.000764	0.00368	CcSEcCtD
Prednisone—Anaemia—Sorafenib—liver cancer	0.000759	0.00366	CcSEcCtD
Prednisone—Angioedema—Sorafenib—liver cancer	0.000751	0.00362	CcSEcCtD
Prednisone—Delirium—Doxorubicin—liver cancer	0.000747	0.0036	CcSEcCtD
Prednisone—Syncope—Sorafenib—liver cancer	0.000737	0.00355	CcSEcCtD
Prednisone—Ulcer—Epirubicin—liver cancer	0.000734	0.00354	CcSEcCtD
Prednisone—Amenorrhoea—Doxorubicin—liver cancer	0.000731	0.00352	CcSEcCtD
Prednisone—Loss of consciousness—Sorafenib—liver cancer	0.000722	0.00348	CcSEcCtD
Prednisone—Viral infection—Doxorubicin—liver cancer	0.000711	0.00343	CcSEcCtD
Prednisone—Hypertension—Sorafenib—liver cancer	0.000709	0.00342	CcSEcCtD
Prednisone—Arthropathy—Doxorubicin—liver cancer	0.000707	0.00341	CcSEcCtD
Prednisone—Myalgia—Sorafenib—liver cancer	0.000699	0.00337	CcSEcCtD
Prednisone—Arthralgia—Sorafenib—liver cancer	0.000699	0.00337	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.000694	0.00335	CcSEcCtD
Prednisone—Hiccups—Epirubicin—liver cancer	0.000694	0.00335	CcSEcCtD
Prednisone—Ulcer—Doxorubicin—liver cancer	0.000679	0.00327	CcSEcCtD
Prednisone—Anaphylactic shock—Sorafenib—liver cancer	0.00067	0.00323	CcSEcCtD
Prednisone—Infection—Sorafenib—liver cancer	0.000666	0.00321	CcSEcCtD
Prednisone—Skin exfoliation—Epirubicin—liver cancer	0.000663	0.0032	CcSEcCtD
Prednisone—Shock—Sorafenib—liver cancer	0.00066	0.00318	CcSEcCtD
Prednisone—Fluid retention—Epirubicin—liver cancer	0.000659	0.00318	CcSEcCtD
Prednisone—Nervous system disorder—Sorafenib—liver cancer	0.000657	0.00317	CcSEcCtD
Prednisone—Neuropathy—Epirubicin—liver cancer	0.000652	0.00314	CcSEcCtD
Prednisone—Skin disorder—Sorafenib—liver cancer	0.000651	0.00314	CcSEcCtD
Prednisone—Hiccups—Doxorubicin—liver cancer	0.000643	0.0031	CcSEcCtD
Prednisone—Anorexia—Sorafenib—liver cancer	0.000639	0.00308	CcSEcCtD
Prednisone—Oesophagitis—Epirubicin—liver cancer	0.000635	0.00306	CcSEcCtD
Prednisone—Ecchymosis—Epirubicin—liver cancer	0.000628	0.00303	CcSEcCtD
Prednisone—Pulmonary oedema—Epirubicin—liver cancer	0.000618	0.00298	CcSEcCtD
Prednisone—Skin exfoliation—Doxorubicin—liver cancer	0.000613	0.00296	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Sorafenib—liver cancer	0.000611	0.00294	CcSEcCtD
Prednisone—Fluid retention—Doxorubicin—liver cancer	0.00061	0.00294	CcSEcCtD
Prednisone—Neuropathy—Doxorubicin—liver cancer	0.000603	0.00291	CcSEcCtD
Prednisone—Sepsis—Epirubicin—liver cancer	0.000603	0.0029	CcSEcCtD
Prednisone—Dyspepsia—Sorafenib—liver cancer	0.00059	0.00284	CcSEcCtD
Prednisone—Oesophagitis—Doxorubicin—liver cancer	0.000587	0.00283	CcSEcCtD
Prednisone—Decreased appetite—Sorafenib—liver cancer	0.000583	0.00281	CcSEcCtD
Prednisone—Thrombophlebitis—Epirubicin—liver cancer	0.000582	0.00281	CcSEcCtD
Prednisone—Ecchymosis—Doxorubicin—liver cancer	0.000581	0.0028	CcSEcCtD
Prednisone—Diabetes mellitus—Epirubicin—liver cancer	0.00058	0.00279	CcSEcCtD
Prednisone—Fatigue—Sorafenib—liver cancer	0.000578	0.00279	CcSEcCtD
Prednisone—Constipation—Sorafenib—liver cancer	0.000573	0.00276	CcSEcCtD
Prednisone—Pulmonary oedema—Doxorubicin—liver cancer	0.000572	0.00276	CcSEcCtD
Prednisone—Vascular purpura—Epirubicin—liver cancer	0.000563	0.00272	CcSEcCtD
Prednisone—Sepsis—Doxorubicin—liver cancer	0.000558	0.00269	CcSEcCtD
Prednisone—Cardiac failure congestive—Epirubicin—liver cancer	0.000556	0.00268	CcSEcCtD
Prednisone—Gastrointestinal pain—Sorafenib—liver cancer	0.000548	0.00264	CcSEcCtD
Prednisone—Thrombophlebitis—Doxorubicin—liver cancer	0.000539	0.0026	CcSEcCtD
Prednisone—Increased appetite—Epirubicin—liver cancer	0.000537	0.00259	CcSEcCtD
Prednisone—Diabetes mellitus—Doxorubicin—liver cancer	0.000536	0.00258	CcSEcCtD
Prednisone—Urticaria—Sorafenib—liver cancer	0.000533	0.00257	CcSEcCtD
Prednisone—Body temperature increased—Sorafenib—liver cancer	0.00053	0.00255	CcSEcCtD
Prednisone—Abdominal pain—Sorafenib—liver cancer	0.00053	0.00255	CcSEcCtD
Prednisone—Purpura—Epirubicin—liver cancer	0.000523	0.00252	CcSEcCtD
Prednisone—Vascular purpura—Doxorubicin—liver cancer	0.000521	0.00251	CcSEcCtD
Prednisone—Cardiac failure—Epirubicin—liver cancer	0.000517	0.00249	CcSEcCtD
Prednisone—Lethargy—Epirubicin—liver cancer	0.000514	0.00248	CcSEcCtD
Prednisone—Cardiac failure congestive—Doxorubicin—liver cancer	0.000514	0.00248	CcSEcCtD
Prednisone—Osteoarthritis—Epirubicin—liver cancer	0.000504	0.00243	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Epirubicin—liver cancer	0.000504	0.00243	CcSEcCtD
Prednisone—Increased appetite—Doxorubicin—liver cancer	0.000496	0.00239	CcSEcCtD
Prednisone—Affect lability—Epirubicin—liver cancer	0.000496	0.00239	CcSEcCtD
Prednisone—Hypersensitivity—Sorafenib—liver cancer	0.000494	0.00238	CcSEcCtD
Prednisone—Face oedema—Epirubicin—liver cancer	0.000487	0.00235	CcSEcCtD
Prednisone—Purpura—Doxorubicin—liver cancer	0.000484	0.00233	CcSEcCtD
Prednisone—Asthenia—Sorafenib—liver cancer	0.000481	0.00232	CcSEcCtD
Prednisone—Cardiac arrest—Epirubicin—liver cancer	0.000479	0.00231	CcSEcCtD
Prednisone—Cardiac failure—Doxorubicin—liver cancer	0.000478	0.0023	CcSEcCtD
Prednisone—Mood swings—Epirubicin—liver cancer	0.000478	0.0023	CcSEcCtD
Prednisone—Lethargy—Doxorubicin—liver cancer	0.000476	0.00229	CcSEcCtD
Prednisone—Pruritus—Sorafenib—liver cancer	0.000474	0.00229	CcSEcCtD
Prednisone—Osteoarthritis—Doxorubicin—liver cancer	0.000466	0.00225	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Doxorubicin—liver cancer	0.000466	0.00225	CcSEcCtD
Prednisone—Dry skin—Epirubicin—liver cancer	0.000462	0.00223	CcSEcCtD
Prednisone—Affect lability—Doxorubicin—liver cancer	0.000459	0.00221	CcSEcCtD
Prednisone—Hypokalaemia—Epirubicin—liver cancer	0.000459	0.00221	CcSEcCtD
Prednisone—Diarrhoea—Sorafenib—liver cancer	0.000459	0.00221	CcSEcCtD
Prednisone—Face oedema—Doxorubicin—liver cancer	0.00045	0.00217	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000445	0.00214	CcSEcCtD
Prednisone—Muscular weakness—Epirubicin—liver cancer	0.000445	0.00214	CcSEcCtD
Prednisone—Cardiac arrest—Doxorubicin—liver cancer	0.000443	0.00214	CcSEcCtD
Prednisone—Dizziness—Sorafenib—liver cancer	0.000443	0.00214	CcSEcCtD
Prednisone—Mood swings—Doxorubicin—liver cancer	0.000442	0.00213	CcSEcCtD
Prednisone—Abdominal distension—Epirubicin—liver cancer	0.000439	0.00211	CcSEcCtD
Prednisone—Dry skin—Doxorubicin—liver cancer	0.000428	0.00206	CcSEcCtD
Prednisone—Pancreatitis—Epirubicin—liver cancer	0.000427	0.00206	CcSEcCtD
Prednisone—Vomiting—Sorafenib—liver cancer	0.000426	0.00205	CcSEcCtD
Prednisone—Hypokalaemia—Doxorubicin—liver cancer	0.000424	0.00205	CcSEcCtD
Prednisone—Rash—Sorafenib—liver cancer	0.000423	0.00204	CcSEcCtD
Prednisone—Dermatitis—Sorafenib—liver cancer	0.000422	0.00204	CcSEcCtD
Prednisone—Headache—Sorafenib—liver cancer	0.00042	0.00202	CcSEcCtD
Prednisone—Muscular weakness—Doxorubicin—liver cancer	0.000411	0.00198	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000411	0.00198	CcSEcCtD
Prednisone—Neutropenia—Epirubicin—liver cancer	0.000407	0.00196	CcSEcCtD
Prednisone—Abdominal distension—Doxorubicin—liver cancer	0.000406	0.00196	CcSEcCtD
Prednisone—Nausea—Sorafenib—liver cancer	0.000398	0.00192	CcSEcCtD
Prednisone—Weight increased—Epirubicin—liver cancer	0.000396	0.00191	CcSEcCtD
Prednisone—Pancreatitis—Doxorubicin—liver cancer	0.000395	0.00191	CcSEcCtD
Prednisone—Weight decreased—Epirubicin—liver cancer	0.000394	0.0019	CcSEcCtD
Prednisone—Hyperglycaemia—Epirubicin—liver cancer	0.000393	0.00189	CcSEcCtD
Prednisone—Neuropathy peripheral—Epirubicin—liver cancer	0.000381	0.00184	CcSEcCtD
Prednisone—Neutropenia—Doxorubicin—liver cancer	0.000377	0.00182	CcSEcCtD
Prednisone—Weight increased—Doxorubicin—liver cancer	0.000367	0.00177	CcSEcCtD
Prednisone—Weight decreased—Doxorubicin—liver cancer	0.000365	0.00176	CcSEcCtD
Prednisone—Hyperglycaemia—Doxorubicin—liver cancer	0.000364	0.00175	CcSEcCtD
Prednisone—Bradycardia—Epirubicin—liver cancer	0.000355	0.00171	CcSEcCtD
Prednisone—Neuropathy peripheral—Doxorubicin—liver cancer	0.000352	0.0017	CcSEcCtD
Prednisone—Haemoglobin—Epirubicin—liver cancer	0.00035	0.00169	CcSEcCtD
Prednisone—Haemorrhage—Epirubicin—liver cancer	0.000349	0.00168	CcSEcCtD
Prednisone—Connective tissue disorder—Epirubicin—liver cancer	0.000343	0.00165	CcSEcCtD
Prednisone—Bradycardia—Doxorubicin—liver cancer	0.000328	0.00158	CcSEcCtD
Prednisone—Eye disorder—Epirubicin—liver cancer	0.000326	0.00157	CcSEcCtD
Prednisone—Haemoglobin—Doxorubicin—liver cancer	0.000324	0.00156	CcSEcCtD
Prednisone—Flushing—Epirubicin—liver cancer	0.000324	0.00156	CcSEcCtD
Prednisone—Haemorrhage—Doxorubicin—liver cancer	0.000323	0.00156	CcSEcCtD
Prednisone—Connective tissue disorder—Doxorubicin—liver cancer	0.000317	0.00153	CcSEcCtD
Prednisone—Angiopathy—Epirubicin—liver cancer	0.000316	0.00153	CcSEcCtD
Prednisone—Immune system disorder—Epirubicin—liver cancer	0.000315	0.00152	CcSEcCtD
Prednisone—Arrhythmia—Epirubicin—liver cancer	0.000312	0.0015	CcSEcCtD
Prednisone—Alopecia—Epirubicin—liver cancer	0.000308	0.00149	CcSEcCtD
Prednisone—Mental disorder—Epirubicin—liver cancer	0.000306	0.00147	CcSEcCtD
Prednisone—Malnutrition—Epirubicin—liver cancer	0.000304	0.00146	CcSEcCtD
Prednisone—Erythema—Epirubicin—liver cancer	0.000304	0.00146	CcSEcCtD
Prednisone—Eye disorder—Doxorubicin—liver cancer	0.000302	0.00145	CcSEcCtD
Prednisone—Flushing—Doxorubicin—liver cancer	0.000299	0.00144	CcSEcCtD
Prednisone—Angiopathy—Doxorubicin—liver cancer	0.000293	0.00141	CcSEcCtD
Prednisone—Clobetasol propionate—CYP1A1—liver cancer	0.000292	0.321	CrCbGaD
Prednisone—Immune system disorder—Doxorubicin—liver cancer	0.000291	0.0014	CcSEcCtD
Prednisone—Arrhythmia—Doxorubicin—liver cancer	0.000288	0.00139	CcSEcCtD
Prednisone—Danazol—ESR1—liver cancer	0.000288	0.317	CrCbGaD
Prednisone—Vision blurred—Epirubicin—liver cancer	0.000286	0.00138	CcSEcCtD
Prednisone—Alopecia—Doxorubicin—liver cancer	0.000285	0.00137	CcSEcCtD
Prednisone—Mental disorder—Doxorubicin—liver cancer	0.000283	0.00136	CcSEcCtD
Prednisone—Ill-defined disorder—Epirubicin—liver cancer	0.000282	0.00136	CcSEcCtD
Prednisone—Malnutrition—Doxorubicin—liver cancer	0.000281	0.00135	CcSEcCtD
Prednisone—Erythema—Doxorubicin—liver cancer	0.000281	0.00135	CcSEcCtD
Prednisone—Anaemia—Epirubicin—liver cancer	0.000281	0.00135	CcSEcCtD
Prednisone—Agitation—Epirubicin—liver cancer	0.000279	0.00134	CcSEcCtD
Prednisone—Malaise—Epirubicin—liver cancer	0.000274	0.00132	CcSEcCtD
Prednisone—Vertigo—Epirubicin—liver cancer	0.000273	0.00131	CcSEcCtD
Prednisone—Syncope—Epirubicin—liver cancer	0.000272	0.00131	CcSEcCtD
Prednisone—Loss of consciousness—Epirubicin—liver cancer	0.000267	0.00129	CcSEcCtD
Prednisone—Vision blurred—Doxorubicin—liver cancer	0.000265	0.00128	CcSEcCtD
Prednisone—Convulsion—Epirubicin—liver cancer	0.000263	0.00127	CcSEcCtD
Prednisone—Hypertension—Epirubicin—liver cancer	0.000262	0.00126	CcSEcCtD
Prednisone—Ill-defined disorder—Doxorubicin—liver cancer	0.000261	0.00126	CcSEcCtD
Prednisone—Anaemia—Doxorubicin—liver cancer	0.00026	0.00125	CcSEcCtD
Prednisone—Arthralgia—Epirubicin—liver cancer	0.000258	0.00125	CcSEcCtD
Prednisone—Myalgia—Epirubicin—liver cancer	0.000258	0.00125	CcSEcCtD
Prednisone—Agitation—Doxorubicin—liver cancer	0.000258	0.00124	CcSEcCtD
Prednisone—Anxiety—Epirubicin—liver cancer	0.000258	0.00124	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000257	0.00124	CcSEcCtD
Prednisone—Discomfort—Epirubicin—liver cancer	0.000255	0.00123	CcSEcCtD
Prednisone—Malaise—Doxorubicin—liver cancer	0.000253	0.00122	CcSEcCtD
Prednisone—Vertigo—Doxorubicin—liver cancer	0.000252	0.00122	CcSEcCtD
Prednisone—Syncope—Doxorubicin—liver cancer	0.000252	0.00121	CcSEcCtD
Prednisone—Oedema—Epirubicin—liver cancer	0.000248	0.00119	CcSEcCtD
Prednisone—Anaphylactic shock—Epirubicin—liver cancer	0.000248	0.00119	CcSEcCtD
Prednisone—Loss of consciousness—Doxorubicin—liver cancer	0.000247	0.00119	CcSEcCtD
Prednisone—Infection—Epirubicin—liver cancer	0.000246	0.00119	CcSEcCtD
Prednisone—Shock—Epirubicin—liver cancer	0.000244	0.00117	CcSEcCtD
Prednisone—Convulsion—Doxorubicin—liver cancer	0.000243	0.00117	CcSEcCtD
Prednisone—Nervous system disorder—Epirubicin—liver cancer	0.000243	0.00117	CcSEcCtD
Prednisone—Hypertension—Doxorubicin—liver cancer	0.000242	0.00117	CcSEcCtD
Prednisone—Tachycardia—Epirubicin—liver cancer	0.000242	0.00117	CcSEcCtD
Prednisone—Skin disorder—Epirubicin—liver cancer	0.000241	0.00116	CcSEcCtD
Prednisone—Hyperhidrosis—Epirubicin—liver cancer	0.00024	0.00115	CcSEcCtD
Prednisone—Arthralgia—Doxorubicin—liver cancer	0.000239	0.00115	CcSEcCtD
Prednisone—Myalgia—Doxorubicin—liver cancer	0.000239	0.00115	CcSEcCtD
Prednisone—Anxiety—Doxorubicin—liver cancer	0.000238	0.00115	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000237	0.00114	CcSEcCtD
Prednisone—Discomfort—Doxorubicin—liver cancer	0.000236	0.00114	CcSEcCtD
Prednisone—Anorexia—Epirubicin—liver cancer	0.000236	0.00114	CcSEcCtD
Prednisone—Oedema—Doxorubicin—liver cancer	0.000229	0.00111	CcSEcCtD
Prednisone—Anaphylactic shock—Doxorubicin—liver cancer	0.000229	0.00111	CcSEcCtD
Prednisone—Infection—Doxorubicin—liver cancer	0.000228	0.0011	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000226	0.00109	CcSEcCtD
Prednisone—Shock—Doxorubicin—liver cancer	0.000226	0.00109	CcSEcCtD
Prednisone—Nervous system disorder—Doxorubicin—liver cancer	0.000225	0.00108	CcSEcCtD
Prednisone—Insomnia—Epirubicin—liver cancer	0.000224	0.00108	CcSEcCtD
Prednisone—Tachycardia—Doxorubicin—liver cancer	0.000224	0.00108	CcSEcCtD
Prednisone—Skin disorder—Doxorubicin—liver cancer	0.000223	0.00107	CcSEcCtD
Prednisone—Paraesthesia—Epirubicin—liver cancer	0.000222	0.00107	CcSEcCtD
Prednisone—Hyperhidrosis—Doxorubicin—liver cancer	0.000222	0.00107	CcSEcCtD
Prednisone—Anorexia—Doxorubicin—liver cancer	0.000219	0.00105	CcSEcCtD
Prednisone—Dyspepsia—Epirubicin—liver cancer	0.000218	0.00105	CcSEcCtD
Prednisone—Decreased appetite—Epirubicin—liver cancer	0.000215	0.00104	CcSEcCtD
Prednisone—Fatigue—Epirubicin—liver cancer	0.000214	0.00103	CcSEcCtD
Prednisone—Constipation—Epirubicin—liver cancer	0.000212	0.00102	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000209	0.00101	CcSEcCtD
Prednisone—Insomnia—Doxorubicin—liver cancer	0.000207	0.000999	CcSEcCtD
Prednisone—Paraesthesia—Doxorubicin—liver cancer	0.000206	0.000992	CcSEcCtD
Prednisone—Feeling abnormal—Epirubicin—liver cancer	0.000204	0.000984	CcSEcCtD
Prednisone—Gastrointestinal pain—Epirubicin—liver cancer	0.000203	0.000977	CcSEcCtD
Prednisone—Dyspepsia—Doxorubicin—liver cancer	0.000202	0.000973	CcSEcCtD
Prednisone—Decreased appetite—Doxorubicin—liver cancer	0.000199	0.000961	CcSEcCtD
Prednisone—Fatigue—Doxorubicin—liver cancer	0.000198	0.000953	CcSEcCtD
Prednisone—Urticaria—Epirubicin—liver cancer	0.000197	0.000949	CcSEcCtD
Prednisone—Constipation—Doxorubicin—liver cancer	0.000196	0.000945	CcSEcCtD
Prednisone—Abdominal pain—Epirubicin—liver cancer	0.000196	0.000944	CcSEcCtD
Prednisone—Body temperature increased—Epirubicin—liver cancer	0.000196	0.000944	CcSEcCtD
Prednisone—Feeling abnormal—Doxorubicin—liver cancer	0.000189	0.000911	CcSEcCtD
Prednisone—Gastrointestinal pain—Doxorubicin—liver cancer	0.000187	0.000904	CcSEcCtD
Prednisone—Hypersensitivity—Epirubicin—liver cancer	0.000183	0.00088	CcSEcCtD
Prednisone—Urticaria—Doxorubicin—liver cancer	0.000182	0.000878	CcSEcCtD
Prednisone—Abdominal pain—Doxorubicin—liver cancer	0.000181	0.000874	CcSEcCtD
Prednisone—Body temperature increased—Doxorubicin—liver cancer	0.000181	0.000874	CcSEcCtD
Prednisone—Asthenia—Epirubicin—liver cancer	0.000178	0.000857	CcSEcCtD
Prednisone—Pruritus—Epirubicin—liver cancer	0.000175	0.000845	CcSEcCtD
Prednisone—Diarrhoea—Epirubicin—liver cancer	0.00017	0.000817	CcSEcCtD
Prednisone—Hypersensitivity—Doxorubicin—liver cancer	0.000169	0.000814	CcSEcCtD
Prednisone—Asthenia—Doxorubicin—liver cancer	0.000164	0.000793	CcSEcCtD
Prednisone—Dizziness—Epirubicin—liver cancer	0.000164	0.00079	CcSEcCtD
Prednisone—Pruritus—Doxorubicin—liver cancer	0.000162	0.000782	CcSEcCtD
Prednisone—Vomiting—Epirubicin—liver cancer	0.000158	0.000759	CcSEcCtD
Prednisone—Diarrhoea—Doxorubicin—liver cancer	0.000157	0.000756	CcSEcCtD
Prednisone—Rash—Epirubicin—liver cancer	0.000156	0.000753	CcSEcCtD
Prednisone—Dermatitis—Epirubicin—liver cancer	0.000156	0.000752	CcSEcCtD
Prednisone—Headache—Epirubicin—liver cancer	0.000155	0.000748	CcSEcCtD
Prednisone—Dizziness—Doxorubicin—liver cancer	0.000152	0.000731	CcSEcCtD
Prednisone—Nausea—Epirubicin—liver cancer	0.000147	0.000709	CcSEcCtD
Prednisone—Vomiting—Doxorubicin—liver cancer	0.000146	0.000703	CcSEcCtD
Prednisone—Rash—Doxorubicin—liver cancer	0.000145	0.000697	CcSEcCtD
Prednisone—Dermatitis—Doxorubicin—liver cancer	0.000144	0.000696	CcSEcCtD
Prednisone—Headache—Doxorubicin—liver cancer	0.000144	0.000692	CcSEcCtD
Prednisone—Nausea—Doxorubicin—liver cancer	0.000136	0.000656	CcSEcCtD
Prednisone—Dexamethasone—CYP2E1—liver cancer	0.000111	0.122	CrCbGaD
Prednisone—Dexamethasone—CYP1A1—liver cancer	0.000109	0.12	CrCbGaD
Prednisone—Methyltestosterone—ALB—liver cancer	0.000108	0.119	CrCbGaD
Prednisone—CYP2C19—Metabolism—TAT—liver cancer	5.93e-05	0.000331	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—HPGDS—liver cancer	5.92e-05	0.00033	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.88e-05	0.000328	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	5.83e-05	0.000325	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—TAT—liver cancer	5.78e-05	0.000323	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—AKT1—liver cancer	5.69e-05	0.000317	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—IL6—liver cancer	5.66e-05	0.000316	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—GSTM1—liver cancer	5.64e-05	0.000315	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—AKT1—liver cancer	5.58e-05	0.000311	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CD—liver cancer	5.58e-05	0.000311	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—PPARG—liver cancer	5.58e-05	0.000311	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IFNA1—liver cancer	5.57e-05	0.000311	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	5.56e-05	0.00031	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—SERPINE1—liver cancer	5.52e-05	0.000308	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—IL6—liver cancer	5.48e-05	0.000306	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PSMA4—liver cancer	5.41e-05	0.000302	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PSMD10—liver cancer	5.41e-05	0.000302	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	5.36e-05	0.000299	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—CYP1A1—liver cancer	5.35e-05	0.000298	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	5.29e-05	0.000295	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PSMA4—liver cancer	5.28e-05	0.000294	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PSMD10—liver cancer	5.28e-05	0.000294	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	5.27e-05	0.000294	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GOT2—liver cancer	5.13e-05	0.000286	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—ALB—liver cancer	5.03e-05	0.000281	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—SERPINE1—liver cancer	5.02e-05	0.00028	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—RAF1—liver cancer	4.98e-05	0.000278	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PRKCE—liver cancer	4.93e-05	0.000275	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—liver cancer	4.91e-05	0.000274	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CB—liver cancer	4.86e-05	0.000271	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.86e-05	0.000271	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP2E1—liver cancer	4.82e-05	0.000269	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—CYCS—liver cancer	4.71e-05	0.000263	CbGpPWpGaD
Prednisone—ALB—Hemostasis—ABL1—liver cancer	4.69e-05	0.000261	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.67e-05	0.000261	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IGF2—liver cancer	4.67e-05	0.00026	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—RAF1—liver cancer	4.55e-05	0.000254	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYCS—liver cancer	4.51e-05	0.000252	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—liver cancer	4.49e-05	0.000251	CbGpPWpGaD
Prednisone—ALB—Metabolism—GLUL—liver cancer	4.49e-05	0.00025	CbGpPWpGaD
Prednisone—ALB—Metabolism—CPT1B—liver cancer	4.49e-05	0.00025	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—IL2—liver cancer	4.47e-05	0.000249	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GGT1—liver cancer	4.43e-05	0.000247	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GOT1—liver cancer	4.43e-05	0.000247	CbGpPWpGaD
Prednisone—ALB—Hemostasis—HGF—liver cancer	4.41e-05	0.000246	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—liver cancer	4.4e-05	0.000246	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	4.36e-05	0.000243	CbGpPWpGaD
Prednisone—ALB—Hemostasis—CSF2—liver cancer	4.36e-05	0.000243	CbGpPWpGaD
Prednisone—ALB—Metabolism—NR1H4—liver cancer	4.33e-05	0.000241	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—liver cancer	4.29e-05	0.000239	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—liver cancer	4.28e-05	0.000239	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTA3—liver cancer	4.25e-05	0.000237	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—liver cancer	4.25e-05	0.000237	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—liver cancer	4.15e-05	0.000231	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—CYCS—liver cancer	4.13e-05	0.00023	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—HMOX1—liver cancer	4.09e-05	0.000228	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—liver cancer	4.05e-05	0.000226	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CPT1B—liver cancer	4.03e-05	0.000225	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GLUL—liver cancer	4.03e-05	0.000225	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—UGDH—liver cancer	4e-05	0.000223	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GSTP1—liver cancer	3.98e-05	0.000222	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CPT1B—liver cancer	3.93e-05	0.000219	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GLUL—liver cancer	3.93e-05	0.000219	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—HMOX1—liver cancer	3.92e-05	0.000219	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTA4—liver cancer	3.89e-05	0.000217	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NR1H4—liver cancer	3.88e-05	0.000217	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTA3—liver cancer	3.82e-05	0.000213	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.8e-05	0.000212	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—VEGFA—liver cancer	3.8e-05	0.000212	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTA2—liver cancer	3.79e-05	0.000212	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NR1H4—liver cancer	3.79e-05	0.000211	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—EPT1—liver cancer	3.76e-05	0.00021	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—liver cancer	3.74e-05	0.000209	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTA3—liver cancer	3.73e-05	0.000208	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTA1—liver cancer	3.66e-05	0.000204	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GSTM1—liver cancer	3.66e-05	0.000204	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—H2AFX—liver cancer	3.65e-05	0.000204	CbGpPWpGaD
Prednisone—ALB—Metabolism—NAT2—liver cancer	3.62e-05	0.000202	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—HMOX1—liver cancer	3.59e-05	0.0002	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—TAT—liver cancer	3.56e-05	0.000199	CbGpPWpGaD
Prednisone—ALB—Hemostasis—MAPK14—liver cancer	3.53e-05	0.000197	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTA4—liver cancer	3.49e-05	0.000195	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—TGFB1—liver cancer	3.48e-05	0.000194	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.48e-05	0.000194	CbGpPWpGaD
Prednisone—ALB—Metabolism—ALDOB—liver cancer	3.47e-05	0.000193	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP1A1—liver cancer	3.47e-05	0.000193	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—liver cancer	3.44e-05	0.000192	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—liver cancer	3.43e-05	0.000191	CbGpPWpGaD
Prednisone—ALB—Hemostasis—F2—liver cancer	3.42e-05	0.000191	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	3.41e-05	0.00019	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTA4—liver cancer	3.41e-05	0.00019	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTA2—liver cancer	3.4e-05	0.00019	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTA2—liver cancer	3.32e-05	0.000185	CbGpPWpGaD
Prednisone—ALB—Metabolism—CRABP1—liver cancer	3.31e-05	0.000185	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—PPARA—liver cancer	3.31e-05	0.000184	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTA1—liver cancer	3.28e-05	0.000183	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CG—liver cancer	3.27e-05	0.000183	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PPARA—liver cancer	3.25e-05	0.000181	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—NAT2—liver cancer	3.25e-05	0.000181	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—MTHFR—liver cancer	3.23e-05	0.00018	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTA1—liver cancer	3.21e-05	0.000179	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—liver cancer	3.2e-05	0.000179	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—MYC—liver cancer	3.18e-05	0.000177	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—liver cancer	3.18e-05	0.000177	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PPARA—liver cancer	3.17e-05	0.000177	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—NAT2—liver cancer	3.17e-05	0.000177	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	3.12e-05	0.000174	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ALDOB—liver cancer	3.11e-05	0.000174	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ALDOB—liver cancer	3.04e-05	0.000169	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MAPK14—liver cancer	3e-05	0.000167	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.98e-05	0.000166	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CRABP1—liver cancer	2.97e-05	0.000166	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CA—liver cancer	2.96e-05	0.000165	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—ESR1—liver cancer	2.94e-05	0.000164	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—liver cancer	2.92e-05	0.000163	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CRABP1—liver cancer	2.9e-05	0.000162	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—PPARA—liver cancer	2.9e-05	0.000162	CbGpPWpGaD
Prednisone—ALB—Metabolism—HPGDS—liver cancer	2.89e-05	0.000161	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CD—liver cancer	2.88e-05	0.00016	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.87e-05	0.00016	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.85e-05	0.000159	CbGpPWpGaD
Prednisone—ALB—Hemostasis—SERPINE1—liver cancer	2.84e-05	0.000159	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—liver cancer	2.82e-05	0.000158	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CG—liver cancer	2.72e-05	0.000151	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PPARG—liver cancer	2.69e-05	0.00015	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	2.67e-05	0.000149	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PPARG—liver cancer	2.62e-05	0.000146	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.62e-05	0.000146	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—HPGDS—liver cancer	2.6e-05	0.000145	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	2.58e-05	0.000144	CbGpPWpGaD
Prednisone—ALB—Metabolism—PSMD10—liver cancer	2.58e-05	0.000144	CbGpPWpGaD
Prednisone—ALB—Metabolism—PSMA4—liver cancer	2.58e-05	0.000144	CbGpPWpGaD
Prednisone—ALB—Hemostasis—RAF1—liver cancer	2.57e-05	0.000143	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—HPGDS—liver cancer	2.53e-05	0.000141	CbGpPWpGaD
Prednisone—ALB—Metabolism—GOT2—liver cancer	2.51e-05	0.00014	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CB—liver cancer	2.51e-05	0.00014	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GLUL—liver cancer	2.42e-05	0.000135	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CPT1B—liver cancer	2.42e-05	0.000135	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—AKT1—liver cancer	2.42e-05	0.000135	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—SERPINE1—liver cancer	2.42e-05	0.000135	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CD—liver cancer	2.39e-05	0.000133	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—liver cancer	2.38e-05	0.000133	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP2E1—liver cancer	2.36e-05	0.000131	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ALB—liver cancer	2.36e-05	0.000131	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	2.35e-05	0.000131	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NR1H4—liver cancer	2.34e-05	0.00013	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	2.32e-05	0.000129	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PSMA4—liver cancer	2.31e-05	0.000129	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PSMD10—liver cancer	2.31e-05	0.000129	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IL2—liver cancer	2.3e-05	0.000128	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTA3—liver cancer	2.3e-05	0.000128	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.28e-05	0.000127	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PSMD10—liver cancer	2.26e-05	0.000126	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PSMA4—liver cancer	2.26e-05	0.000126	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GOT2—liver cancer	2.25e-05	0.000126	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—RAF1—liver cancer	2.22e-05	0.000124	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYCS—liver cancer	2.21e-05	0.000123	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GOT2—liver cancer	2.2e-05	0.000123	CbGpPWpGaD
Prednisone—ALB—Metabolism—GGT1—liver cancer	2.16e-05	0.000121	CbGpPWpGaD
Prednisone—ALB—Metabolism—GOT1—liver cancer	2.16e-05	0.000121	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—ALB—liver cancer	2.15e-05	0.00012	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP2E1—liver cancer	2.12e-05	0.000118	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTA4—liver cancer	2.1e-05	0.000117	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CB—liver cancer	2.08e-05	0.000116	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP2E1—liver cancer	2.07e-05	0.000115	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.05e-05	0.000114	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTA2—liver cancer	2.05e-05	0.000114	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYCS—liver cancer	1.98e-05	0.00011	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTA1—liver cancer	1.97e-05	0.00011	CbGpPWpGaD
Prednisone—ALB—Hemostasis—VEGFA—liver cancer	1.96e-05	0.000109	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—NAT2—liver cancer	1.95e-05	0.000109	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—RAF1—liver cancer	1.95e-05	0.000109	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTP1—liver cancer	1.94e-05	0.000108	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GOT1—liver cancer	1.94e-05	0.000108	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GGT1—liver cancer	1.94e-05	0.000108	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYCS—liver cancer	1.93e-05	0.000108	CbGpPWpGaD
Prednisone—ALB—Metabolism—HMOX1—liver cancer	1.92e-05	0.000107	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GOT1—liver cancer	1.9e-05	0.000106	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GGT1—liver cancer	1.9e-05	0.000106	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ALDOB—liver cancer	1.87e-05	0.000104	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TGFB1—liver cancer	1.8e-05	0.0001	CbGpPWpGaD
Prednisone—ALB—Metabolism—GSTM1—liver cancer	1.79e-05	9.97e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CRABP1—liver cancer	1.79e-05	9.96e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTP1—liver cancer	1.75e-05	9.74e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—HMOX1—liver cancer	1.72e-05	9.6e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTP1—liver cancer	1.7e-05	9.5e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP1A1—liver cancer	1.69e-05	9.45e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—HMOX1—liver cancer	1.68e-05	9.37e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—KRAS—liver cancer	1.66e-05	9.28e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GSTM1—liver cancer	1.6e-05	8.95e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—MTHFR—liver cancer	1.58e-05	8.81e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GSTM1—liver cancer	1.57e-05	8.73e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—HPGDS—liver cancer	1.56e-05	8.71e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PPARA—liver cancer	1.55e-05	8.64e-05	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MYC—liver cancer	1.53e-05	8.54e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CA—liver cancer	1.53e-05	8.53e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP1A1—liver cancer	1.52e-05	8.48e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP1A1—liver cancer	1.48e-05	8.28e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TP53—liver cancer	1.48e-05	8.25e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—MTHFR—liver cancer	1.42e-05	7.91e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—HRAS—liver cancer	1.41e-05	7.89e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.39e-05	7.76e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PSMA4—liver cancer	1.39e-05	7.76e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PSMD10—liver cancer	1.39e-05	7.76e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PPARA—liver cancer	1.39e-05	7.76e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—MTHFR—liver cancer	1.38e-05	7.72e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PPARA—liver cancer	1.36e-05	7.57e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GOT2—liver cancer	1.35e-05	7.55e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CG—liver cancer	1.33e-05	7.4e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PPARG—liver cancer	1.28e-05	7.14e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP2E1—liver cancer	1.27e-05	7.1e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CA—liver cancer	1.27e-05	7.07e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.25e-05	6.97e-05	CbGpPWpGaD
Prednisone—ALB—Hemostasis—AKT1—liver cancer	1.25e-05	6.96e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CG—liver cancer	1.19e-05	6.64e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYCS—liver cancer	1.19e-05	6.64e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GGT1—liver cancer	1.17e-05	6.52e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GOT1—liver cancer	1.17e-05	6.52e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CD—liver cancer	1.17e-05	6.51e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CG—liver cancer	1.16e-05	6.48e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PPARG—liver cancer	1.15e-05	6.41e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PPARG—liver cancer	1.12e-05	6.26e-05	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—AKT1—liver cancer	1.06e-05	5.92e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTP1—liver cancer	1.05e-05	5.85e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CD—liver cancer	1.05e-05	5.84e-05	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—AKT1—liver cancer	1.04e-05	5.78e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—HMOX1—liver cancer	1.04e-05	5.77e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ALB—liver cancer	1.03e-05	5.76e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CD—liver cancer	1.02e-05	5.7e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CB—liver cancer	1.02e-05	5.67e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ALB—liver cancer	1.01e-05	5.63e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GSTM1—liver cancer	9.64e-06	5.38e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP1A1—liver cancer	9.14e-06	5.1e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CB—liver cancer	9.12e-06	5.09e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CB—liver cancer	8.91e-06	4.97e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—MTHFR—liver cancer	8.52e-06	4.75e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PPARA—liver cancer	8.36e-06	4.66e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CG—liver cancer	7.16e-06	3.99e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PPARG—liver cancer	6.91e-06	3.86e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CD—liver cancer	6.3e-06	3.51e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ALB—liver cancer	6.21e-06	3.47e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CA—liver cancer	6.2e-06	3.46e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CA—liver cancer	5.56e-06	3.1e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CB—liver cancer	5.49e-06	3.06e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CA—liver cancer	5.43e-06	3.03e-05	CbGpPWpGaD
Prednisone—ALB—Metabolism—AKT1—liver cancer	5.06e-06	2.82e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—AKT1—liver cancer	4.54e-06	2.53e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—AKT1—liver cancer	4.44e-06	2.47e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CA—liver cancer	3.35e-06	1.87e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—AKT1—liver cancer	2.73e-06	1.52e-05	CbGpPWpGaD
